Help Advance Lifesaving Research: Columbia University Study Needs Blood Donors of Diverse Backgrounds
- Jaime P. Morales
- 11 minutes ago
- 3 min read
Currently Recruiting
Join a Groundbreaking Blood Donor Study at Columbia University Irving Medical Center
Columbia University Irving Medical Center and NewYork-Presbyterian Hospital are currently conducting a vital research study that could improve the quality of blood transfusions and deepen our understanding of how genetics and COVID-19 interact. If you’re a male between the ages of 18 and 65 and of African, Asian, Hispanic, Middle Eastern, or Mediterranean descent, your participation could help move science forward in a big way.
Statistical Data of Covid-19
The COVID-19 pandemic profoundly impacted lives across the globe. While much has been learned about this devastating virus, many questions remain. Today, researchers continue to explore new insights that could help people better prepare for and respond to future public health threats.
Scientific research plays a critical role in understanding the broader effects of COVID-19, particularly through the collection and analysis of key data.
According to data reported by APM Research Lab (as of September 27, 2023), the toll on different racial and ethnic groups in the U.S. includes:
Black Americans: Approximately 156,000 to 157,000 deaths
Latino Americans: At least 172,235 deaths
Pacific Islander Americans: At least 2,323 deaths
White Americans: At least 759,258 deaths
Indigenous (Native American) Americans: At least 12,122 deaths
Asian Americans: At least 35,967 deaths
This data highlights the disproportionate impact the pandemic had on many communities, emphasizing the ongoing need for inclusive public health strategies and continued scientific study.
Why This Study Matters
Every year, millions of people rely on blood transfusions. But did you know that genetic differences can affect red blood cell quality and how blood performs in transfusions? This study is designed to explore exactly that. Additionally, researchers are investigating how COVID-19 and your immune response may have influenced your health long-term.
By taking part in this study, you can play a key role in helping doctors better match blood donors and recipients, potentially improving outcomes for patients around the world.
Study Highlights
Here’s a quick breakdown of what to expect:
Who Can Join:Males ages 18–65 of African, Asian, Hispanic, Middle Eastern, or Mediterranean descent
Purpose of the Study:
Understand how genetics affect red blood cells used in transfusions
Determine how COVID-19 exposure or antibodies might influence your body’s response
Support future innovations in transfusion medicine and pandemic preparedness
What You’ll Do:
Provide a small blood sample from your arm
Complete a 15-minute study visit
Answer basic health and COVID-19 screening questions
What You’ll Get:
A monetary incentive for your participation
A chance to qualify for future studies
The satisfaction of helping advance lifesaving medical research
No Risks to Your Care:
Participation is completely voluntary
Your choice to participate will not affect your care at Columbia University or NewYork-Presbyterian
Ready to Learn More?
If you're interested or want to see if you're eligible, simply call the study team directly at:(212) 342-5648 / Email: yf2370@cumc.columbia.edu
Why Diverse Participation Matters
Researchers have long known that genetic diversity is essential to making medical treatments work for everyone, not just a narrow subset of the population. Historically, people from underrepresented communities have been left out of medical studies, which can lead to gaps in treatment effectiveness and equity.
By participating, you're helping make medical care more accurate and inclusive for everyone.
Be Part of the Change
This is your chance to take part in meaningful research that could improve health care for future generations. Even just 15 minutes of your time could have a big impact.
Comentários